Repligen (RGEN) Free Cash Flow (2010 - 2026)
Repligen (RGEN) posted quarterly Free Cash Flow of $27.4 million for Q2 2026, up 27.54% year-over-year from $21.5 million in Q2 2025, and up 16.31% quarter-over-quarter from $23.6 million in Q1 2026.
Repligen (RGEN) Free Cash Flow (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Free Cash Flow for 17 consecutive years, with $27.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow rose 27.54% year-over-year to $27.4 million; the TTM figure through Jun 2026 stood at $112.0 million (up 2.79% YoY), while the FY2025 annual figure was $93.9 million, down 37.28% from the prior year.
- Free Cash Flow grew to $27.4 million in Q2 2026 per RGEN's latest filing, from $23.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $43.4 million in Q3 2025 and bottomed at -$4.1 million in Q1 2022.
- Historically, Free Cash Flow has averaged $25.5 million across 5 years, with a median of $26.8 million in 2023.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 343.8% — and 2024, when it jumped 1274.74%.
- Repligen's Free Cash Flow stood at $41.4 million in 2022, then sank by 56.61% to $18.0 million in 2023, then jumped by 87.1% to $33.6 million in 2024, then plunged by 47.82% to $17.6 million in 2025, then surged by 56.3% to $27.4 million in 2026.
- Business Quant data shows RGEN's Free Cash Flow at $27.4 million in Q2 2026, $23.6 million in Q1 2026, and $17.6 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 948.40 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 633.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 136.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 403.50 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 604.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 80.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 144.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 96.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 181.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 27.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.43 Mn |
| Jun 30, 2026 | 27.43 Mn |
| Mar 31, 2026 | 23.59 Mn |
| Mar 31, 2026 | 23.59 Mn |
| Dec 31, 2025 | 17.55 Mn |
| Dec 31, 2025 | 17.55 Mn |
| Sep 30, 2025 | 43.40 Mn |
| Sep 30, 2025 | 43.40 Mn |
| Jun 30, 2025 | 21.51 Mn |
| Jun 30, 2025 | 21.51 Mn |
| Mar 31, 2025 | 11.44 Mn |
| Mar 31, 2025 | 11.44 Mn |
| Dec 31, 2024 | 33.64 Mn |
| Dec 31, 2024 | 33.64 Mn |
| Sep 30, 2024 | 42.34 Mn |
| Sep 30, 2024 | 42.34 Mn |
| Jun 30, 2024 | 37.38 Mn |
| Jun 30, 2024 | 37.38 Mn |
| Mar 31, 2024 | 36.36 Mn |
| Mar 31, 2024 | 36.36 Mn |